Clara Gregori-Pla

Clara Gregori-Pla

Auto-generated profile, based on publicly available information

Clara Gregori-Pla

ICFO-Institut de Ciències Fotòniques, The Barcelona Institute of Science and Technology, Av. Carl Friedrich Gauss, 3, Castelldefels (Barcelona), 08860 , Spain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2018 in Neurophotonics
Verified
Journal Article
Open access
PDF file
MGMartina Giovannella
Martina Giovannella
DIDavid Ibañez
David Ibañez
CGClara Gregori-Pla
Clara Gregori-Pla
MKMichal Kacprzak
Michal Kacprzak
GMGuillem Mitjà
Guillem Mitjà
Turgut DurduranTurgut Durduran
Turgut Durduran
Transcranial current stimulation (tCS) is a noninvasive form of brain stimulation that applies weak direct electrical currents to the brain through electrodes placed on the scalp. Different types of stimulation are available based on how the current delivered to the brain is modulated.1 The most common approach is to hold the current constant during the stimulation period, this is known as transcranial direct current stimulation (tDCS). This method is commonly referred to as tDCS, but in order to avoid confusion with the optical method, we here use DC-tCS. DC-tCS induces bidirectional, polarity-dependent changes in cerebral excitability of humans2,3 and has been shown to modulate cognition in both healthy subjects (improvement of cognitive function) and in patients (reversing the effects of cognitive deficits after a stroke).4,5 Positive effects have also been shown in treatment of depression, chronic and acute pain, Parkinson’s disease, focal epilepsy, and for improving recovery after stroke.6 7. 8. – 9 A therapeutic application of this technique is appealing due to its relative low cost, to its demonstrated safety,10 and as a substitute for pharmacotherapy, especially for patients with poor drug tolerability.8

9 February 2019 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
CGClara Gregori-Pla
Clara Gregori-Pla
IBIgor Blanco
Igor Blanco
PCPol Camps-Renom
Pol Camps-Renom
PZPeyman Zirak
Peyman Zirak
ISIsabel Serra
Isabel Serra
RDRaquel Delgado-Mederos
Raquel Delgado-Mederos

9 April 2021 in BMC Neurology
Verified
Journal Article
Open access
PDF file
CGClara Gregori-Pla
Clara Gregori-Pla
RMRickson C. Mesquita
Rickson C. Mesquita
CFChristopher G. Favilla
Christopher G. Favilla
DBDavid R. Busch
David R. Busch
IBIgor Blanco
Igor Blanco
RDRaquel Delgado-Mederos
Raquel Delgado-Mederos
Background: The cortical microvascular cerebral blood flow response (CBF) to different changes in head-of-bed (HOB) position has been shown to be altered in acute ischemic stroke (AIS) by diffuse correlation spectroscopy (DCS) technique. However, the relationship between these relative ΔCBF changes and associated systemic blood pressure changes has not been studied, even though blood pressure is a major driver of cerebral blood flow. Methods: Transcranial DCS data from four studies measuring bilateral frontal microvascular cerebral blood flow in healthy controls (n = 15), patients with asymptomatic severe internal carotid artery stenosis (ICA, n = 27), and patients with acute ischemic stroke (AIS, n = 72) were aggregated. DCS-measured CBF was measured in response to a short head-of-bed (HOB) position manipulation protocol (supine/elevated/supine, 5 min at each position). In a sub-group (AIS, n = 26; ICA, n = 14; control, n = 15), mean arterial pressure (MAP) was measured dynamically during the protocol. Results: After elevated positioning, DCS CBF returned to baseline supine values in controls (p = 0.890) but not in patients with AIS (9.6% [6.0,13.3], mean 95% CI, p < 0.001) or ICA stenosis (8.6% [3.1,14.0], p = 0.003)). MAP in AIS patients did not return to baseline values (2.6 mmHg [0.5, 4.7], p = 0.018), but in ICA stenosis patients and controls did. Instead ipsilesional but not contralesional CBF was correlated with MAP (AIS 6.0%/mmHg [− 2.4,14.3], p = 0.038; ICA stenosis 11.0%/mmHg [2.4,19.5], p < 0.001). Conclusions: The observed associations between ipsilateral CBF and MAP suggest that short HOB position changes may elicit deficits in cerebral autoregulation in cerebrovascular disorders. Additional research is required to further characterize this phenomenon.

19 June 2023 in SLEEP
Verified
Journal Article
Open access
PDF file
CGClara Gregori-Pla
Clara Gregori-Pla
PZPeyman Zirak
Peyman Zirak
GCGianluca Cotta
Gianluca Cotta
PBPau Bramon
Pau Bramon
IBIgor Blanco
Igor Blanco
MMMercedes Mayos
Mercedes Mayos
We aimed to characterize the cerebral hemodynamic response to obstructive sleep apnea/hypopnea events, and evaluate their association to polysomnographic parameters. The characterization of the cerebral hemodynamics in obstructive sleep apnea (OSA) may add complementary information to further the understanding of the severity of the syndrome beyond the conventional polysomnography. Severe OSA patients were studied during night sleep while monitored by polysomnography. Transcranial, bed-side diffuse correlation spectroscopy (DCS) and frequency‐domain near-infrared diffuse correlation spectroscopy (NIRS-DOS) were used to follow microvascular cerebral hemodynamics in the frontal lobes of the cerebral cortex. Changes in cerebral blood flow (CBF), total hemoglobin concentration (THC), and cerebral blood oxygen saturation (StO2) were analyzed. We considered 3283 obstructive apnea/hypopnea events from sixteen OSA patients (Age (median, interquartile range) 57 (52‐64.5); females 25%; AHI (apnea‐hypopnea index) 84.4 (76.1‐93.7)). A biphasic response (maximum/minimum followed by a minimum/maximum) was observed for each cerebral hemodynamic variable (CBF, THC, StO2), heart rate and peripheral arterial oxygen saturation (SpO2). Changes of the StO2 followed the dynamics of the SpO2, and were out of phase from the THC and CBF. Longer events were associated with larger CBF changes, faster responses and slower recoveries. Moreover, the extrema of the response to obstructive hypopneas were lower compared to apneas (p < .001). Obstructive apneas/hypopneas cause profound, periodic changes in cerebral hemodynamics, including periods of hyper- and hypo-perfusion and intermittent cerebral hypoxia. The duration of the events is a strong determinant of the cerebral hemodynamic response, which is more pronounced in apnea than hypopnea events.

3 November 2018 in Neurophotonics
Verified
Journal Article
Open access
PDF file
PZPeyman Zirak
Peyman Zirak
CGClara Gregori-Pla
Clara Gregori-Pla
IBIgor Blanco
Igor Blanco
AFAna Fortuna
Ana Fortuna
GCGianluca Cotta
Gianluca Cotta
MMMercedes Mayos
Mercedes Mayos
Obstructive sleep apnea (OSA) is characterized by the intermittent and repetitive collapse of the upper airway during sleep with simultaneous respiratory effort. Symptoms such as headache, sleepiness, fatigue, depression and difficulties in keeping concentration are frequent in patients with OSA.1 Even more, OSA has been related to an increased risk of cardiovascular and cerebrovascular diseases, such as systemic hypertension, atrial fibrillation, and cerebral stroke,2 3. 4. – 5 as well as to increased mortality.6,7 The key factors involved are the repetitive intermittent hypoxia, the increased sympathetic activity, the sleep fragmentation, and the periodic cerebral hemodynamic changes but further understanding is desirable.8,9

14 March 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CGClara Gregori-Pla
Clara Gregori-Pla
GCGianluca Cotta
Gianluca Cotta
IBIgor Blanco
Igor Blanco
PZPeyman Zirak
Peyman Zirak
MGMartina Giovannella
Martina Giovannella
MMMercedes Mayos
Mercedes Mayos
Obstructive sleep apnea (OSA) can impair cerebral vasoreactivity and is associated with an increased risk of cerebrovascular disease. Unfortunately, an easy-to-use, non-invasive, portable monitor of cerebral vasoreactivity does not exist. Therefore, we have evaluated the use of near-infrared diffuse correlation spectroscopy to measure the microvascular cerebral blood flow (CBF) response to a mild head-of-bed position change as a biomarker for the evaluation of cerebral vasoreactivity alteration due to chronic OSA. Furthermore, we have monitored the effect of two years of continuous positive airway pressure (CPAP) treatment on the cerebral vasoreactivity. CBF was measured at different head-of-bed position changes (supine to 30° to supine) in sixty-eight patients with OSA grouped according to severity (forty moderate to severe, twenty-eight mild) and in fourteen control subjects without OSA. A subgroup (n = 13) with severe OSA was measured again after two years of CPAP treatment. All patients and controls showed a similar CBF response after changing position from supine to 30° (p = 0.819), with a median (confidence interval) change of -17.5 (-10.3, -22.9)%. However, when being tilted back to the supine position, while the control group (p = 0.091) and the mild patients with OSA (p = 0.227) recovered to the initial baseline, patients with moderate and severe OSA did not recover to the baseline (9.8 (0.8, 12.9)%, p < 0.001) suggesting altered cerebral vasoreactivity. This alteration was correlated with OSA severity defined by the apnea-hypopnea index, and with mean nocturnal arterial oxygen saturation. The CBF response was normalized after two years of CPAP treatment upon follow-up measurements. In conclusion, microvascular CBF response to a head-of-bed challenge measured by diffuse correlation spectroscopy suggests that moderate and severe patients with OSA have altered cerebral vasoreactivity related to OSA severity. This may normalize after two years of CPAP treatment.